Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tissue Expansion;”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05826600
What this trial is testing

OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

Who this might be right for
Solid Tumor
iOmx Therapeutics AG 68
Not applicableStudy completedNCT06763406
What this trial is testing

The Effects of Schroth Based Exercise Therapy in Adolescents with Pectus Excavatum

Who this might be right for
Pectus ExcavatumPectus Excavatum DeformityFunnel Chest+1 more
Hacettepe University 35
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Not applicableStudy completedNCT05803330
What this trial is testing

Study of Alpha-blockers Alone During Preoperative Preparation in Patients With Pheochromocytoma

Who this might be right for
Adrenal PheochromocytomaHemodynamic
Kunwu Yan,MM 95
Testing effectiveness (Phase 2)Looking for participantsNCT05573126
What this trial is testing

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

Who this might be right for
Hormone Receptor-positive Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerMetastatic Breast Cancer
Ellipses Pharma 95
Testing effectiveness (Phase 2)Study completedNCT03993678
What this trial is testing

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Swiss Cancer Institute 28
Early research (Phase 1)Ended earlyNCT03292172
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer

Who this might be right for
Advanced Ovarian CancerTriple Negative Breast Cancer
Hoffmann-La Roche 36
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Very early researchLooking for participantsNCT06072586
What this trial is testing

BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Who this might be right for
High Grade GliomaGlioblastoma
St. Joseph's Hospital and Medical Center, Phoenix 82
Early research (Phase 1)Temporarily pausedNCT06968988
What this trial is testing

Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma

Who this might be right for
Metastatic Soft-tissue Sarcoma
Washington University School of Medicine 18
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Very early researchNot Yet RecruitingNCT07784985
What this trial is testing

NST-628 in Recurrent Grade 4 Glioma

Who this might be right for
Glioma, Recurrent High GradeGrade 4 Malignant Glioma
Nader Sanai 12
Testing effectiveness (Phase 2)Looking for participantsNCT05123482
What this trial is testing

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Who this might be right for
Breast CancerBiliary Tract CarcinomaOvarian Cancer+2 more
AstraZeneca 460
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)Looking for participantsNCT05970497
What this trial is testing

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerMelanoma Stage IIIMelanoma Stage IV+1 more
Krystal Biotech, Inc. 240
Early research (Phase 1)Active Not RecruitingNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Early research (Phase 1)Study completedNCT02375958
What this trial is testing

PCA062 in pCAD-positive Tumors.

Who this might be right for
Triple Negative Breast CancerHead & Neck CancerEsophageal Cancer
Novartis Pharmaceuticals 47
Not applicableStudy completedNCT03874923
What this trial is testing

Comparison of 250 ml Versus 500 ml of Fluid Challenge

Who this might be right for
Fluid ChallengeOxygen ConsumptionCritical Care
Centre Hospitalier Universitaire, Amiens 24
Early research (Phase 1)Study completedNCT04293094
What this trial is testing

Study of AMG 650 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Volastra Therapeutics, Inc. 66
Not applicableLooking for participantsNCT02821806
What this trial is testing

Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy

Who this might be right for
Healthy Volunteer
National Cancer Institute (NCI) 500
Next Page